Web Results


Solvay S.A. is a Belgian chemical company founded in 1863, with its head office in Neder-Over-Heembeek, Brussels, Belgium. In 2015, it realized 12.4 billion € in revenues, 2.336 billion € of REBITDA, 43% of its sales in emerging high-growth countries, 90% of its sales in markets where it is ranked among the top three ...


May 27, 2015 ... The pharmaceutical segment includes a wide range of applications and functionalities such as API, excipient, packaging and medical devices.


As an international chemical group, Solvay assists industries in finding and implementing ever more responsible and value-creating solutions. The Group is firmly committed to sustainable development and focused on innovation and operational excellenc.


Solvay Pharmaceuticals, Inc. is now part of Abbott (February 2010). See: Abbott Laboratories. Latest Drug Information Updates. Erleada Erleada (apalutamide) is an oral androgen receptor inhibitor for the treatment of men with non-metastatic... Symdeko Symdeko (ivacaftor / tezacaftor tablets and ivacaftor tablets) is a cystic ...


Solvay Pharmaceuticals is a research driven group of companies that constitute the global pharmaceutical business of the Solvay Group. The company seeks to fulfill carefully selected, unmet medica ...


Feb 16, 2010 ... Abbott Laboratories Completes Acquisition of Solvay Pharmaceuticals, Inc. - read this article along with other careers information, tips and advice on BioSpace.


The Solvay group has been present in this region since 1970 and has more than 50 employees on two sites involved in manufacture and distribution of its' products. Solvay manufactures hydrogen peroxide and related products at its Banksmeadow site in Sydney as well as importing and distributing a range of other ...


Solvay Pharmaceuticals Limited - Pharmaceutical Drugs, Anti HIV & Hepatitis Drugs & Cancer Drugs Manufacturer from Kanpur, Uttar Pradesh, India.


Rx for Global Intelligence, Solvay Pharmaceuticals enhances worldwide drug development efforts with SAS. Shortening drug development cycles is a primary goal of all pharmaceutical companies. But the need is compounded when companies lack sufficient means for sharing the data used in collaborative research efforts ...